Nivea M. F. Voelkner, Alexander Voelkner, Hartmut Derendorf
{"title":"Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats","authors":"Nivea M. F. Voelkner, Alexander Voelkner, Hartmut Derendorf","doi":"10.1002/cpph.58","DOIUrl":null,"url":null,"abstract":"<p>The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal pharmacokinetics facilitates the selection of new compounds or chemical structures for advancement as possible clinical candidates. An advantage of microdialysis is that it allows the measurement of compound concentrations at the site of action without disturbing the tissue milieu, making it possible to determine the relationship between this important variable and plasma concentrations of the agent. Described in this unit are laboratory protocols for performing dermal microdialysis experiments in rat for the purpose of defining the pharmacokinetics parameters of test agents. © 2019 by John Wiley & Sons, Inc.</p>","PeriodicalId":10871,"journal":{"name":"Current Protocols in Pharmacology","volume":"85 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpph.58","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpph.58","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 4
Abstract
The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal pharmacokinetics facilitates the selection of new compounds or chemical structures for advancement as possible clinical candidates. An advantage of microdialysis is that it allows the measurement of compound concentrations at the site of action without disturbing the tissue milieu, making it possible to determine the relationship between this important variable and plasma concentrations of the agent. Described in this unit are laboratory protocols for performing dermal microdialysis experiments in rat for the purpose of defining the pharmacokinetics parameters of test agents. © 2019 by John Wiley & Sons, Inc.
微透析取样法测定大鼠皮肤药代动力学
评估候选药物在作用部位的吸收和利用度是药物发现和开发的重要因素,因为临床反应是活性药物的生物利用度及其在作用部位的持续存在的函数。皮肤药代动力学的评估有助于选择新的化合物或化学结构作为可能的临床候选物。微透析的一个优点是,它允许在不干扰组织环境的情况下测量作用部位的化合物浓度,从而有可能确定这一重要变量与药物血浆浓度之间的关系。本单元描述了在大鼠身上进行皮肤微透析实验的实验室方案,目的是确定试验剂的药代动力学参数。©2019 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。